A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
Public ClinicalTrials.gov record NCT05014412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE A DOSING REGIMEN WITH TWO STEP-UP PRIMING DOSES AND LONGER DOSING INTERVALS OF ELRANATAMAB (PF-06863135) MONOTHERAPY IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Study identification
- NCT ID
- NCT05014412
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- Elranatamab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 6, 2021
- Primary completion
- Jun 14, 2023
- Completion
- Dec 11, 2025
- Last update posted
- Feb 9, 2026
2021 – 2025
United States locations
- U.S. sites
- 35
- U.S. states
- 11
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| Poudre Valley Hospital | Fort Collins | Colorado | 80524 | — |
| Cancer Care & Hematology - Fort Collins | Fort Collins | Colorado | 80528 | — |
| Poudre Valley Health System (PVHS) | Fort Collins | Colorado | 80528 | — |
| UCHealth Cancer Care & Hematology - Greeley | Greeley | Colorado | 80634 | — |
| UCHealth Cancer Care & Hematology - Loveland | Loveland | Colorado | 80538 | — |
| UF Health Shands Cancer Hospital | Gainesville | Florida | 32608 | — |
| UF Health Shands Hospital Pharmacy Investigational Drug Service - Main | Gainesville | Florida | 32610 | — |
| UF Health Shands Hospital | Gainesville | Florida | 32610 | — |
| East Jefferson General Hospital Bone Marrow Transplant Clinic | Metairie | Louisiana | 70006 | — |
| East Jefferson General Hospital | Metairie | Louisiana | 70006 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| The Regents of the University of Michigan | Ann Arbor | Michigan | 48109 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| MSK Basking Ridge | Basking Ridge | New Jersey | 07920 | — |
| MSK Monmouth | Middletown | New Jersey | 07748 | — |
| MSK Bergen | Montvale | New Jersey | 07645 | — |
| MSK Commack | Commack | New York | 11725 | — |
| MSK Westchester | Harrison | New York | 10604 | — |
| Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy | Long Island City | New York | 11101 | — |
| Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). | New York | New York | 10021 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| MSK Nassau | Uniondale | New York | 11553 | — |
| Cleveland Clinic Taussig Cancer Institute | Cleveland | Ohio | 44195 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| St. David's South Austin Medical Center | Austin | Texas | 78704 | — |
| Texas Oncology-South Austin | Austin | Texas | 78745 | — |
| Blood Cancer and Stem Cell Transplant Clinic | San Antonio | Texas | 78229 | — |
| Methodist Healthcare System of San Antonio dba Methodist Hospital | San Antonio | Texas | 78229 | — |
| Methodist Hospital Investigational Pharmacy | San Antonio | Texas | 78229 | — |
| Methodist Plaza Clinical Trials Office | San Antonio | Texas | 78229 | — |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | Utah | 84112 | — |
| University of Utah | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05014412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05014412 live on ClinicalTrials.gov.